The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.
Executives Respond to the State of the Industry Report on Risk-Based Approaches in Clinical Trials: Opportunity or Threat?
Dennis Salotti, MBA, MS
Vice President, Operations
The Avoca Group, United States
Part didactic presentation, part lively debate and discussion among an executive panel, dive deep into the state of risk in clinical trials and explore our data on risk assessment and risk-based approaches to clinical trial oversight and execution.
Learning Objective : Identify the most recent information regarding the state of the industry for familiarity, use, impact and satisfaction with risk assessment and risk-based approaches in clinical research; Develop new perspectives on how to shape their individual and organizational perspectives and positioning with respect to changing regulatory requirements and evolving risk landscape.
Executive Vice President, Clinical Quality and Compliance
ICON Clinical Research, United States
Elizabeth Luczak, MBA
Vice President, R&D Quality Assurance
Vertex Pharmaceuticals, United States